申请人:Prana Biotechnology Limited
公开号:EP2210892A2
公开(公告)日:2010-07-28
Compounds of formula Ie, or a salt, hydrate, solvate, derivative, pro-drug, tautomer and/or isomer thereof:
wherein R, R1, m and q are as defined in the claims, and their use as pharmaceutical or veterinary agents, in particular for the treatment of neurological conditions including Alzheimer's disease.
式 Ie 的化合物或其盐、水合物、溶液、衍生物、原药、同分异构体和/或异构体:
其中 R、R1、m 和 q 如权利要求书中所定义,以及它们作为药物或兽药的用途,特别是用于治疗包括阿尔茨海默氏症在内的神经系统疾病。